IRRAS AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IRRAS.ST research report →
Companywww.irras.com
IRRAS AB (publ), a medical device company, focuses on the delivery of medical solutions to enhance the lives of critically ill patients worldwide. It designs, develops, and commercializes neurocritical care products that transform patient outcomes and addresses complications associated with current treatment methodologies. The company offers IRRAflow, an irrigating intracranial drainage system that combines controlled drainage, automated irrigation, and integrated monitoring of intracranial pressure (ICP) for the treatment of patients suffering from hemorrhagic strokes and chronic subdural hematoma.
- CEO
- Will Martin
- IPO
- 2017
- Employees
- 47
- HQ
- Stockholm, SE
Price Chart
Valuation
- Market Cap
- $181.75M
- P/E
- -0.31
- P/S
- 4.54
- P/B
- 0.35
- EV/EBITDA
- -0.80
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 20.91%
- Op Margin
- -420.25%
- Net Margin
- -416.53%
- ROE
- -129.31%
- ROIC
- -110.30%
Growth & Income
- Revenue
- $40.00M · 78.67%
- Net Income
- $-166,604,000 · -22.13%
- EPS
- $-0.52 · 16.13%
- Op Income
- $-168,090,000
- FCF YoY
- -30.09%
Performance & Tape
- 52W High
- $0.60
- 52W Low
- $0.11
- 50D MA
- $0.17
- 200D MA
- $0.24
- Beta
- 1.73
- Avg Volume
- 551.32K
Get TickerSpark's AI analysis on IRRAS.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our IRRAS.ST Coverage
We haven't published any research on IRRAS.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IRRAS.ST Report →